Literature DB >> 7917876

Hodgkin's disease following steroid-resistant idiopathic nephrotic syndrome.

G Deschênes, C Allard, S Benoit, O Lejars, J P Lamagnére, H Nivet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917876     DOI: 10.1007/bf00866377

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  7 in total

1.  Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition.

Authors:  A V Moorthy; S W Zimmerman; P M Burkholder
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

2.  Pefloxacin as first-line treatment in nephrotic syndrome.

Authors:  A Pruna; F Metivier; K Akposso; C Saltiel; J Bedrossian; J M Idatte; D Nochy; P Druet
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

Review 3.  Spontaneously remitting minimal change nephropathy preceding a relapse of Hodgkin's disease by 19 months.

Authors:  Z Korzets; E Golan; Y Manor; M Schneider; J Bernheim
Journal:  Clin Nephrol       Date:  1992-09       Impact factor: 0.975

Review 4.  Glomerulopathies of neoplasia.

Authors:  J W Eagen
Journal:  Kidney Int       Date:  1977-05       Impact factor: 10.612

5.  Cyclosporin A-sensitive nephrotic syndrome preceding Hodgkin's disease by 32 months.

Authors:  D Fouque; M Laville; S Colon; M French; F Berger; M Labeeuw; P Zech
Journal:  Clin Nephrol       Date:  1990-07       Impact factor: 0.975

6.  Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.

Authors:  P Niaudet; M Broyer; R Habib
Journal:  Clin Nephrol       Date:  1991       Impact factor: 0.975

7.  Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.

Authors: 
Journal:  Clin Nephrol       Date:  1991       Impact factor: 0.975

  7 in total
  1 in total

1.  Nephrotic syndrome and Hodgkin lymphoma in children. Report of two cases.

Authors:  A Pourtsidis; D Doganis; M Baka; M Varvoutsi; H Kosmidis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.